StockData
IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31

INNOSPEC INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$97.99+1.18 (+1.22%)

Close on Oct 19, 2026

Market cap
$2.42B
P/E (TTM)
21.0
Dividend yield
1.75%

Earnings

Next report expected Nov 4, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 5, 2026Before market open$491.40M$1.25$1.27
Q1 FY2026
Ended Mar 31, 2026
May 8, 2026Before market open$453.20M$1.22$1.05
Q4 FY2025
Ended Dec 31, 2025
Feb 18, 2026Before market open$455.60M$1.91$1.50
Q3 FY2025
Ended Sep 30, 2025
Nov 5, 2025Before market open$441.90M$0.52$1.12
Q2 FY2025
Ended Jun 30, 2025
Aug 6, 2025Before market open$439.70M$0.94$1.26
Q1 FY2025
Ended Mar 31, 2025
May 9, 2025Before market open$440.80M$1.31$1.42
Q4 FY2024
Ended Dec 31, 2024
Feb 19, 2025Before market open$466.80M$-2.80$1.41
Q3 FY2024
Ended Sep 30, 2024
Nov 6, 2024Before market open$443.40M$1.33$1.35
Q2 FY2024
Ended Jun 30, 2024
Aug 7, 2024Before market open$435.00M$1.24$1.39
Q1 FY2024
Ended Mar 31, 2024
May 10, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 14, 2024Before market open–––

Press releases

Announcements Innospec filed with the SEC